TFF Group (OTCMKTS:FRFTF) Short Interest Update

TFF Group (OTCMKTS:FRFTF) was the recipient of a large growth in short interest during the month of July. As of July 15th, there was short interest totaling 13,860 shares, a growth of 334.8% from the June 30th total of 3,188 shares. Based on an average daily trading volume, of 113 shares, the short-interest ratio is currently 122.7 days.

TFF Group Price Performance

OTCMKTS:FRFTF opened at C$17.50 on Monday. The stock’s 50 day simple moving average is C$17.50 and its 200-day simple moving average is C$18.77. TFF Group has a 12-month low of C$17.50 and a 12-month high of C$20.14.

TFF Group Company Profile

TFF Group (OTCMKTS:FRFTF) is a clinical-stage specialty pharmaceutical company developing and commercializing medicines based on its proprietary thin-film drug delivery platform. The company’s core technology transforms active pharmaceutical ingredients into solid films that dissolve rapidly in the oral cavity or adhere to mucosal surfaces, enabling precise dosing without water, potential improvements in bioavailability and the opportunity to create novel dosage forms. TFF Group’s platform supports a broad range of molecules, from small-molecule drugs and peptides to vaccines and biologics.

Headquartered in Kansas City, Missouri, with research and manufacturing facilities in Europe, TFF Group applies its thin-film technology across multiple therapeutic areas, including central nervous system disorders, hormone replacement therapy, respiratory diseases and vaccines.